	GLP-1 RA Prescribing in Patients With Type 2 Diabetes and Cancer. JAMA Netw Open Hu X, Jiang C, Han X, Zhang L, Li P, Pasquel FJ, Meisel JL, Vo JB, Varghese JS, Shao H, Graetz I. PMID: 42944687 [PubMed - indexed for MEDLINE]
	Characterizing bone metastases and skeletal-related events in patients with well-differentiated neuroendocrine neoplasms utilizing (68)Gallium-DOTATATE positron emission tomography. J Neuroendocrinol Coston TW, Mahadevia HJ, Plante MM, Hochwald A, Accurso JM, Sharma A, Johnson GB, Ashman JB, Kendi AT, Sonbol MB, McGarrah PW, Hobday TJ, Halfdanarson TR, Starr JS. PMID: 42944559 [PubMed - indexed for MEDLINE]
	PG-SGA, GLIM, and CONUT in Hepatopancreatobiliary Cancer: Complementary Tools for Different Clinical Questions. J Clin Med Stefanoudakis D, Frountzas M, Karaniki E, Vouros D, Emmanouil A, Lidoriki I, Kokala-Dimitropoulou V, Theodorou D, Schizas D, Toutouzas KG. PMID: 42941397 [PubMed]
	Serum Cytokine Profiling in Pancreatic Ductal Adenocarcinoma: A Pilot Study of Candidate Discriminators, Sex Differences and Altered Co-Regulation. Biomolecules García-Gómez J, Agredano-Pérez S, Rubio-Delgado DA, Aguilar-Lemarroy A, Jave-Suárez LF, Guevara-Hernández SN, Bravo-Cuéllar A, Méndez-Clemente AS, Hernández-Flores G, Villaseñor-García MM. PMID: 42939746 [PubMed - indexed for MEDLINE]
	Longitudinal Circulating Nerve Growth Factor in Pancreatic Ductal Adenocarcinoma: An Exploratory Study of Postoperative Recurrence and First-Line Disease Control. Biomolecules Garajová I, Digiacomo G, Cavazzoni A, Wang B, Verze M, Minari R, Agnetti V, Giovannetti E. PMID: 42939686 [PubMed - indexed for MEDLINE]
	Diabetes and Cancer-Pathophysiology and Clinical Implications: A Systematic Review. Curr Issues Mol Biol Hasan Z, Moni ZA, Kamal T, Hossain MM, Kabir Y, Islam F. PMID: 42939624 [PubMed]
	Early Local Tumour Control and Feasibility of Intratumoral P-32 Microparticle Implantation in Patients with Locally Advanced Pancreatic Cancer: A Prospective Single-Center Observational Cohort Study. Cancers (Basel) Kontos A, Riris I, Kypraios D, Alexakis N, Zografos G, Toutouzas K. PMID: 42938864 [PubMed]
	Urinary Biomarkers in Cancer: A Scoping Review. Cancers (Basel) Kurotova E, Shah J, Pueyo Valles L, Burke E, Berreby R, Lu YJ, Debernardi S, Crnogorac-Jurcevic T. PMID: 42938862 [PubMed]
	Plasma Protein Corona Fingerprinting Across Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma: A Comparative Proof-of-Concept Study. Cancers (Basel) Aita SE, La Vaccara V, Cammarata R, Talarico M, Giordano F, Coppola R, Caputo D. PMID: 42938812 [PubMed]
	Artificial Intelligence in Pancreatic Cancer: From Predictive Performance to Clinical Translation. Cancers (Basel) Khan I, Belhaj A, Gemini A, Ibis KA, Darsif N, Rouani N, Vanlander A, Messaoudi N. PMID: 42938791 [PubMed]
	When Genomic Scars Outlive Genomic Vulnerability: Dynamic DNA Damage Repair in Cancer Evolution and Therapeutic Resistance. Genes (Basel) Ottaiano A, Sabbatino F, Carratù AC, Cascella M, Barone A, Perri F, Belli A, Columbro A, Izzo F, Valeriani M, Correra M, Nasti G, Savarese G. PMID: 42938366 [PubMed - indexed for MEDLINE]
	Graph Neural Network Modelling of Pre-Diagnostic Serum Proteomics for Pancreatic Cancer Detection. Diagnostics (Basel) Zaikin A, Gentry-Maharaj A, Apostolidou S, Menon U, Trukhanov A, Oganezova JG, Whitwell HJ, Blyuss O. PMID: 42938123 [PubMed]
	Microbial-derived metabolites in cancer: evidence boundaries, immune mechanisms and translational pathways. Front Immunol Shi X, Wang S, Ouyang W. PMID: 42935951 [PubMed - indexed for MEDLINE]
	Treating a systemic disease as a local one: failure points of current pancreatic cancer management and a multimodal, biology-guided framework for redesign. Front Oncol Sewell PE. PMID: 42935847 [PubMed]
	Type 1 and 2 subclassification may be a promising approach to evaluate intraductal papillary neoplasm and intraductal oncocytic neoplasm of the bile duct. Histol Histopathol Nakanuma Y, Fukumura Y, Kakuda Y, Kawashima A, Harada K, Ohishi T. PMID: 42935318 [PubMed - as supplied by publisher]
	Rethinking evidence generation in gastrointestinal cancer treatment research: the need for both high-quality interventional and observational evidence. BMC Med Pellat A, Boutron I, Porcher R, Tran VT, Ravaud P. PMID: 42934650 [PubMed - indexed for MEDLINE]
	Burdens of pancreatic cancer from 1990 to 2021 and projection to 2050 in China: findings from the 2021 global burden of disease study. BMC Cancer Yang F, Bian J, He X, Xu D. PMID: 42934594 [PubMed - indexed for MEDLINE]
	Body image distress in women and men with advanced pancreatic cancer approaching death - post-hoc analyses from the MISTRAL-trial. Support Care Cancer Goodrose-Flores C, Bonn SE, Björkhem-Bergman L, Wode K. PMID: 42934316 [PubMed - indexed for MEDLINE]
	Hereditary Pancreatic Cancer. Gastroenterol Clin North Am Levinson E, Hilfrank K, Rustgi SD, Kastrinos F. PMID: 42933936 [PubMed - indexed for MEDLINE]
	Pancreatic mucinous cystic neoplasms in adults: An update on the role of CT and MRI for risk stratification. Eur J Radiol Nguyen TTL, Barat M, Marchese U, Dohan A, Hoeffel C, Rouquette A, Pellat A, Soyer P. PMID: 42933251 [PubMed - as supplied by publisher]

Articles 1 - 20 / 61981

Page 1 of 3100



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy